• Drug Coverage
  • Hypertrophic Cardiomyopathy (HCM)
  • Vaccines: 2023 Year in Review
  • Eyecare
  • Urothelial Carcinoma
  • Women's Health
  • Hemophilia
  • Heart Failure
  • Vaccines
  • Neonatal Care
  • NSCLC
  • Type II Inflammation
  • Substance Use Disorder
  • Gene Therapy
  • Lung Cancer
  • Spinal Muscular Atrophy
  • HIV
  • Post-Acute Care
  • Liver Disease
  • Pulmonary Arterial Hypertension
  • Safety & Recalls
  • Biologics
  • Asthma
  • Atrial Fibrillation
  • Type I Diabetes
  • RSV
  • COVID-19
  • Cardiovascular Diseases
  • Breast Cancer
  • Prescription Digital Therapeutics
  • Reproductive Health
  • The Improving Patient Access Podcast
  • Blood Cancer
  • Ulcerative Colitis
  • Respiratory Conditions
  • Multiple Sclerosis
  • Digital Health
  • Population Health
  • Sleep Disorders
  • Biosimilars
  • Plaque Psoriasis
  • Leukemia and Lymphoma
  • Oncology
  • Pediatrics
  • Urology
  • Obstetrics-Gynecology & Women's Health
  • Opioids
  • Solid Tumors
  • Autoimmune Diseases
  • Dermatology
  • Diabetes
  • Mental Health

Employees are Looking in to new Benefits During Enrollment Season

Article

U.S. workers plan to spend more time reviewing their healthcare options and enrolling in new benefits during this enrollment period

U.S. workers plan to spend more time reviewing their healthcare options and enrolling in new benefits during this enrollment period, according to a survey by employee benefits provider, Unum. Employees also plan to pay more attention to the benefits their employers offer.

The survey, compiled of 1,500 full-time U.S. workers in August 2021, shared more than half of workers said they are more likely to stay with their employer because of the benefits their employer provides. However, the same amount of employees (57%) plan to enroll in benefits they were not enrolled in this year because they (68%) are more concerned about planning their family's financial needs, (66%) interested in company benefits, and (42%) concerned about their mental health.

"Choosing your benefits is one of the most important financial decisions you'll make this year," said Rob Hecker, vice president of Global Total Rewards at Unum. "The ongoing pandemic reminds us of the need to be prepared. You can protect you and your family's financial future with the right benefits."

Data from the survey found new trends due to the ongoing pandemic:

  • 2 in 3 workers (67%) plan to pay more attention and spend more time reviewing their employee benefits.
  • Generous PTO and paid family leave are the benefits most important to full-time U.S. workers. More than one third (37%) of workers say generous PTO is most important to them. While 36% said paid family leave is most important.
  • The number of workers looking for a new job has almost doubled since spring. According to a PricewaterhouseCoopers pulse survey, 65% of workers are on the hunt for a new job.
  • More than half of workers (56%) are more likely to stay with their current employer because of the benefits package.

Eight in 10 employers believe the pandemic has made employees more interested in or aware of the benefits the organization offers.

An article by NPR recommends to learn what's predictable about your health and to educate yourself further on what plans can offer you. Most importantly, it's crucial to be aware of your deadline.

Related Videos
Video 3 - "In-Office Procedures, Over-the-Counter Options, Treatment Delays, and Costs"
Video 6 - "Safety Analysis and Interpreting Results from MAJIC-PV"
Video 5 - "Key Findings from MAJIC-PV"
Video 2 - "Traditional Treatment of Demodex Blepharitis, FDA approval, and Lotilaner Ophthalmic Solution, 0.25%"
Gabriela Hobbs, MD, an expert on polycythemia vera
Gabriela Hobbs, MD, and Timothy Mok, PharmD, BCPS, BCOP
Video 1 - "Demodex Blepharitis: Prevalence, Symptoms, Quality of Life Impact, and Diagnosis"
Video 2 - "The Role of Ruxolitinib in Managing Hydroxyurea Resistance or Intolerance"
Video 1 - "Prevalence and Impact of Hydroxyurea Intolerance or Resistance in Polycythemia Vera"
Related Content
© 2024 MJH Life Sciences

All rights reserved.